News

XTL Biopharmaceuticals announced that Mr. Alex Rabinovich has been appointed as a member of the Company's board of directors. Mr. Rabinovich is a leading investor in XTL and holds over…
Read More...

Array BioPharma announced that Shalini Sharp, Chief Financial Officer and Executive Vice President of Ultragenyx Pharmaceutical Inc., joined the company's Board of Directors, effective…
Read More...

Merck announced the divestment of its Biosimilars business to Fresenius. The decision to divest Biosimilars is aligned with Merck’s strategy for its Healthcare business sector to focus…
Read More...

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to…
Read More...

MEDITE Cancer Diagnostics specializing in the development, manufacturing and marketing of molecular biomarkers and premium medical devices for detection, risk assessment and diagnosis…
Read More...

Agios Pharmaceuticals and Aurigene Discovery Technologies announced that they have signed a global license agreement to research, develop and commercialize small molecule inhibitors of…
Read More...

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who…
Read More...

Savara Inc., a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare…
Read More...

Valeant Pharmaceuticals International, Inc.'s wholly owned subsidiary, Bausch + Lomb, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)…
Read More...

Results from the phase 3 REPROVE study assessing Pfizer's fixed-dose antibacterial combo Zavicefta (ceftazidime-avibactam) in patients with hospital-acquired pneumonia (HAP)…
Read More...

Science 37 has raised $29m in Series C funding, led by Glynn Capital Management with participation from GV, to bring clinical trials directly into patients’ homes. The round included…
Read More...

scPharmaceuticals announced that John Tucker has been appointed as president and CEO and also elected to the board of directors effective immediately. Mr. Tucker holds a BA from…
Read More...

INTREXON Corporation announced the appointment of Lupin's CEO Vinita Gupta to its Board of Directors effective from April 25, 2017. Ms. Gupta has served as CEO of India-based Lupin…
Read More...

Sutro Biopharma Inc named Crestovo CEO and COO Joseph M. Lobacki to its board of directors. Mr. Lobacki previously served as chief commercial officer of Medivation. He also served…
Read More...

Servier and CTI BioPharma Corp.  jointly announced that they will expand their existing license and development collaboration agreement for PIXUVRI (pixantrone). Under the expanded…
Read More...

According to the study published in the journal of the American Academy of Ophthalmology, the researchers used deep-learning methods to create an automated algorithm to detect diabetic…
Read More...

CryoLife announced that the results from the On-X aortic heart valve PROACT study will be presented in a late-breaking session at the AATS (American Association for Thoracic Surgery)…
Read More...

Amcor, a global leader in the packaging industry, is investing in another state-of-the-art UV Flexo printing press in Alzira, Spain. As part of a broader investment programme, the…
Read More...

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, announced that it…
Read More...

The U.S. Food and Drug Administration today posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent,…
Read More...